HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,256 | +5.9% | 7,991 | 0.0% | 0.11% | +14.3% |
| Q2 2023 | $288,235 | +43.6% | 7,991 | +52.1% | 0.10% | +32.4% |
| Q1 2023 | $200,688 | -34.6% | 5,255 | -32.4% | 0.07% | -45.6% |
| Q3 2022 | $307,000 | +12.5% | 7,769 | +25.3% | 0.14% | +20.4% |
| Q2 2022 | $273,000 | +33.8% | 6,199 | +21.4% | 0.11% | +63.8% |
| Q1 2022 | $204,000 | -11.3% | 5,108 | -10.6% | 0.07% | 0.0% |
| Q4 2021 | $230,000 | -0.9% | 5,712 | 0.0% | 0.07% | -5.5% |
| Q3 2021 | $232,000 | -10.4% | 5,712 | 0.0% | 0.07% | -8.8% |
| Q2 2021 | $259,000 | +8.8% | 5,712 | 0.0% | 0.08% | +6.7% |
| Q1 2021 | $238,000 | – | 5,712 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |